Medicine
Dopamine 400 mg/10 mL injection
Dopamine 400 mg/10 mL injection is a generic prescription medicine for intravenous use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 to 25°C (68 to 77°F).
Key facts
- Active ingredient (INN)
- Dopamine
- Brand
- Sold under the generic name
- Strength
- 400 mg/10 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 mL, 25 pouches of 10 mL, 25 vials of 10 mL and 3 more
- Manufacturers
- Health FirstHealthFirstHenry ScheinHikma PharmaceuticalsHospira
- Origin register
- US FDA, United States
- Storage
- Store at 20 to 25°C (68 to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01CA04 Dopamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 June 2005
- Identifiers
- RxCUI 1743938, 1743941, 1743950 +1DailyMed set ID c6c8539b-0da9-2d97-e053-2a95a90a3aa8, 0e499952-46c7-4172-8c70-186312e240a3, fc1eb709-ce72-413e-9043-8e463ef0fd36 +2NDC 51662-1490, 0143-9254, 0404-9981 +2Application ANDA207707, NDA018132
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 mL in 1 vial, single-dose | 51662-1220-1 | Health First | 23 August 2018 |
| 25 pouch in 1 case / 1 vial, single-dose in 1 pouch / 10 mL in 1 vial, single-dose | 51662-1220-3 | Health First | 10 November 2022 |
| 25 vial, single-dose in 1 carton / 10 mL in 1 vial, single-dose | 0143-9254-25 | Hikma Pharmaceuticals | 11 April 2018 |
| 25 vial, single-dose in 1 tray / 10 mL in 1 vial, single-dose | 0409-9104-20 | Hospira | 30 June 2005 |
| 10 mL in 1 vial, single-dose | 51662-1490-1 | HealthFirst | 10 July 2021 |
| 1 vial, single-dose in 1 bag / 10 mL in 1 vial, single-dose | 0404-9981-10 | Henry Schein | 17 February 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dopamine
Clinical summary
Dopamine is a catecholamine indicated to improve hemodynamic status in patients in distributive shock or shock due to reduced cardiac output. It is available as injection for intravenous use. MedsAcross supplies Dopamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DopamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DOPamine Hydrochloride prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
- Neoatricon: European public assessment report (EPAR) · European Medicines Agency
Need Dopamine 400 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.